2019-04-09T11:21:17-05:00 2018-06-30 410746749 CLIFTONLARSONALLEN LLP 801 FELIX STREET ST JOSEPH MO 64501 990 2017-07-01 431266906 PKD FOUNDATION PKDF 8169312600 1001 E 101ST TER NO 220 KANSAS CITY MO 64131 ANDY BETTS CHIEF EXECUTIVE OFFICER 8169312600 2019-04-08 1 HAROLD RAY CPA P01248589 8162328441 67.137.57.251 2019-04-08 15:12:23 CD P DB1167B47F5D429246047FDDEAC3BD44F12AAEB1 7E873DF7359C7EA4C949E13DC1E9CC8C179B1BD0 2017 2019-02-21 02:37:17Z X ANDY BETTS 1001 E 101ST TER NO 220 KANSAS CITY MO 64131 15112193 0 X WWW.PKDCURE.ORG X 1982 MO PROMOTE PROGRAMS OF RESEARCH AND EDUCATION TO DISCOVER TREATMENTS AND A CURE FOR PKD. 18 18 48 2530 0 0 5709118 12652147 0 0 114587 170904 -35147 127794 5788558 12950845 1531349 1412624 0 0 2720408 3134496 46142 235896 1310343 1822437 2948197 6120336 7731213 -331778 5219632 5218772 11398154 503054 1354476 4715718 10043678 X PROMOTE PROGRAMS OF RESEARCH, ADVOCACY, EDUCATION, SUPPORT AND AWARENESS IN ORDER TO DISCOVER TREATMENTS AND A CURE FOR POLYCYSTIC KIDNEY DISEASE AND IMPROVE THE LIVES OF ALL IT AFFECTS. 0 0 2536220 1412624 RESEARCH:SINCE ITS FOUNDING IN 1982, THE PKD FOUNDATION HAS INVESTED MORE THAN $44 MILLION IN RESEARCH, CLINICAL AND SCIENTIFIC GRANTS, AS WELL AS FELLOWSHIPS AND SCIENTIFIC MEETINGS, MAKING US THE LARGEST PRIVATE FUNDER OF POLYCYSTIC KIDNEY DISEASE (PKD) RESEARCH. THIS HAS LED TO NEW DISCOVERIES ABOUT PKD, INCLUDING IDENTIFYING THE GENES RESPONSIBLE FOR PKD, WHICH ENABLES RESEARCHERS TO INVESTIGATE POSSIBLE TREATMENTS. THE FOUNDATION HAS A COMPREHENSIVE, INTEGRATED RESEARCH AND DEVELOPMENT PROGRAM THAT REPRESENTS THE CORE OF OUR WORK, AIMED TO SPEED UP DEVELOPMENT OF TREATMENTS WHICH COULD SLOW OR STOP THE PROGRESSION OF PKD. THE FOUNDATION'S FISCAL YEAR INVESTMENTS IN RESEARCH IS OUTLINED BELOW.RESEARCH GRANTS: INVESTED $1,160,000 ON GRANT FUNDING TO 15 PKD PROJECTS THAT FOCUS ON THE DEVELOPMENT OF A TREATMENT FOR PKD OR ON UNDERSTANDING THE WAY IN WHICH CYSTS DEVELOP OR ENLARGE IN PKD.FELLOWSHIPS: PROVIDED $110,724 IN FELLOWSHIP FUNDING TO 4 PKD PROJECTS.CORE GRANTS: INVESTED $40,000 TO SUPPORT CORE RESEARCH GRANTS SERVICES AND RESOURCES FOR PKD SCIENTISTS IN TWO CORE LABS SO THAT FOUNDATION DOLLARS CAN BE LEVERAGED ACROSS THE PKD RESEARCH COMMUNITY. 1073903 4327 EDUCATION AND SUPPORT:THE FOUNDATION PROVIDES LOCAL SERVICES THROUGH ITS MORE THAN 60 VOLUNTEER-RUN CHAPTERS ACROSS THE COUNTRY. THESE VOLUNTEERS BRING TO LIFE THE MISSION OF THE ORGANIZATION BY ENSURING THAT NO ONE FACES THIS DISEASE ALONE. EDUCATION MEETINGS PROVIDE VALUABLE INFORMATION FROM HEALTH CARE PROFESSIONALS, WHILE SUPPORT ACTIVITIES RANGE FROM LENDING A LISTENING EAR TO ORGANIZED GROUP OUTINGS. THIS YEAR ALONE, OUR CHAPTERS HELD 109 EDUCATION AND SUPPORT EVENTS.CHAPTERS RAISE FUNDS FOR THE FOUNDATION THROUGH EVENTS WHICH ALSO INCREASE AWARENESS OF PKD AND CONNECT LOCAL PATIENTS AND FAMILIES TO EACH OTHER. NINETY ONE CHAPTER FUNDRAISING AND THIRD- PARTY EVENTS WERE HELD THIS YEAR THAT RAISED $469,170. CHAPTERS ALSO RAISE AWARENESS AND MONEY THROUGH THE WALK FOR PKD, THE FOUNDATION'S SIGNATURE FUNDRAISING AND PUBLIC AWARENESS EVENT. THE WALK TAKES PLACE IN MORE THAN 50 CITIES ACROSS THE NATION EACH YEAR AND HAS RAISED NEARLY $28 MILLION SINCE 2000.ON A NATIONAL LEVEL, THE FOUNDATION PROVIDES IN-DEPTH RESOURCES AND EDUCATION ABOUT LIVING WITH PKD TO EMPOWER PEOPLE TO MANAGE THEIR HEALTH. OFFERINGS INCLUDE WEBINARS, VIDEOS, A MULTI-FACETED WEBSITE (PKDCURE.ORG/LEARN), ONLINE COMMUNITIES AND PRINT MATERIALS. ADDITIONALLY, 10 WEBINARS WERE ATTENDED OR VIEWED BY MORE THAN 819 PEOPLE.THE PKD PATIENT HANDBOOK IS AVAILABLE FOR PEOPLE WITH ADPKD TO HELP THEM NAVIGATE THEIR DISEASE. IT WAS SENT TO 731 PEOPLE LAST YEAR. 1837483 AWARENESS AND ADVOCACY:THE FOUNDATION RAISES AWARENESS THROUGH MARKETING AND PUBLIC RELATIONS SO PEOPLE KNOW WHAT PKD IS, ABOUT THE FOUNDATION AND HOW TO DONATE. MARKETING MATERIALS INCLUDE PKD PROGRESS MAGAZINE, PKDNEWS MONTHLY EMAIL NEWSLETTER, SOCIAL MEDIA, DISCUSSION FORUMS, BLOGS AND PKDCURE.ORG. VOICES OF PKD (PKDCURE.ORG/VOICESOFPKD) FEATURES TESTIMONIALS AND STORIES ABOUT PEOPLE'S EXPERIENCES WITH THE DISEASE. THERE WAS A SIGNIFICANT INCREASE ON SOCIAL MEDIA, REACHING MORE THAN 45,000 FOLLOWERS INCLUDING FACEBOOK, TWITTER, INSTAGRAM AND YOUTUBE. PKDCURE.ORG RECEIVED 644,578 VISITS, PKDCONNECTION.ORG RECEIVED 34,196 VISIT, WALKFORPKD.ORG RECEIVED 191,443 VISITS. DISCUSSION FORUMS RECEIVED 23,014 VISITS.THE FOUNDATION PLAYS A KEY ROLE IN LEGISLATIVE ADVOCACY TO SUPPORT PKD-RELATED INITIATIVES. THE PKD ADVOCACY ACTION CENTER (PKDCURE.ORG/ADVOCATE) SENT ADVOCACY ALERTS TO 6,500 PEOPLE ABOUT LEGISLATIVE AND PUBLIC POLICY ISSUES IMPACTING PKD PATIENTS AND FAMILIES. THE FOUNDATION JOINS WITH OTHER KIDNEY DISEASE-RELATED ORGANIZATIONS IN EVENTS THAT ALLOW ADVOCATES TO MEET WITH MEMBERS OF CONGRESS TO RAISE AWARENESS OF PKD AND DISCUSS LEGISLATIVE PRIORITIES. 5447606 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 1 1 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 18 0 48 1 0 0 0 0 0 1 1 0 0 0 0 X 18 18 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AK AL AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN MS NC ND NH NJ NM NV NY OH OK OR PA RI SC TN UT VA WA WI WV X X X RUSS PETRY 8169312600 1001 E 101ST TER NO 220 KANSAS CITY MO 64131 X BISSLER JOHN DIRECTOR 1.00 X 0 0 0 BROWN ASHLEY DIRECTOR 1.00 X 0 0 0 BRAZELL BILL DIRECTOR 1.00 X 0 0 0 HURCHINSON PAULA DIRECTOR 1.00 X 0 0 0 KARL MICHELE DIRECTOR 1.00 X 0 0 0 KRINGSTEIN ANDREA DIRECTOR 1.00 X 0 0 0 MRUG MICHAL DIRECTOR 1.00 X 0 0 0 ODLAND DWIGHT DIRECTOR 1.00 X 0 0 0 RAMSEYER CRAIG DIRECTOR 1.00 X 0 0 0 RONA JEFFREY DIRECTOR 1.00 X 0 0 0 RYAN ANNE DIRECTOR 1.00 X 0 0 0 TOWEY JR FRAN DIRECTOR 1.00 X 0 0 0 WATNICK DR TERRY DIRECTOR 1.00 X 0 0 0 WAXMAN JERRY DIRECTOR 1.00 X 0 0 0 BENSON DR BEVERLY SECRETARY 1.00 X X 0 0 0 NELSON BROCK TREASURER 1.00 X X 0 0 0 COWLEY JR DR BENJAMIN VICE CHAIR 2.00 X X 0 0 0 KLEBER KLEE CHAIR 2.00 X X 0 0 0 BETTS ANDREW CEO 40.00 X 220000 0 21597 SMITH RAY CFO:LEFT JUL 17 40.00 X 31483 0 2016 BARON DAVID CHIEF SCIENTIFIC OFFICER 40.00 X 205920 0 39444 KENNETH MCLAUGHLIN CHIEF OPERATING OFFICER 40.00 X 119583 0 17000 576986 0 80057 3 0 1 0 0 12652147 1286841 12652147 100878 100878 2224741 2154715 70026 70026 70026 4327 6633 -2306 -2306 INSURANCE PROCEEDS 900099 130000 130000 MISCELLANEOUS INCOME 900099 100 100 130100 12950845 -2306 0 301004 X 1292624 1292624 120000 120000 284090 156249 28409 99432 2178760 1221722 545344 411694 144089 80635 33792 29662 324818 181782 76303 66733 202739 113437 47290 42012 97861 61133 19081 17647 27000 14974 6248 5778 60000 60000 235896 235896 16741 16741 1053055 965644 37546 49865 186389 186389 290931 230373 30782 29776 99438 55989 17603 25846 189365 105029 43816 40520 768743 518059 31785 218899 89064 49393 20606 19065 15498 8596 3586 3316 DUES, FEES, MEMBERSHIPS 54112 25578 14332 14202 7731213 5447606 973264 1310343 X 130705 228084 1303737 3156801 177030 3772108 51290 12287 31084 0 51837 8089 582826 304473 136924 278353 3316937 3925474 19228 16958 5218772 11398154 243087 754476 166667 0 93300 600000 503054 1354476 X 3553782 3917718 161936 5125960 1000000 1000000 4715718 10043678 5218772 11398154 X 5219632 74465 33863 X X 0 1 X 1 0 X 6811982 7539923 5881314 5709118 12652147 38594484 6811982 7539923 5881314 5709118 12652147 38594484 3230309 35364175 2444 7014 31733 73444 100878 215513 129434 10839 30462 39617 130100 340452 39150449 20400 0.90330 0.95050 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2013 AMOUNT: $ 377. 2014 AMOUNT: $ 89. 2015 AMOUNT: $ 162. 2016 AMOUNT: $ 737. 2017 AMOUNT: $ 130,100. GROSS REVENUE FROM FUNDRAISING EVENTS - 2013 AMOUNT: $ 129,057. 2014 AMOUNT: $ 10,750. 2015 AMOUNT: $ 30,300. 2016 AMOUNT: $ 38,880. 2017 AMOUNT: $ 0. 60000 60000 7661938 7721938 536097 134024 0 0 474909 481510 456460 536097 1948976 2923464 30381 85018 58865 60000 234264 118727 120378 114115 134024 487244 730866 2960433 1021831 222220 108000 16741 4079744 2773007 310566 108000 15140 2960433 2700000 77487 4480 2773007 0.75490 0.24510 0.00000 0 0 582826 304473 278353 278353 X 13458451 74465 418661 31221 524347 12934104 16741 16741 12950845 8130491 418661 -2642 416019 7714472 16741 16741 7731213 PART V, LINE 4: THE PURPOSE OF THE RESEARCH OPPORTUNITY FUND AND NAMED ENDOWMENTS (COLLECTIVELY REFERRED TO AS "ENDOWMENTS") IS TO PROVIDE FOR GROWTH-ORIENTED LONG-TERM INVESTMENT OF FUNDS THAT ARE NOT NEEDED TO MEET THE DAY-TO-DAY FINANCIAL OBLIGATIONS OF THE FOUNDATION. PART X, LINE 2: THE FOUNDATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE. THE FOUNDATION DOES NOT OPERATE AS A PRIVATE FOUNDATION. ALTHOUGH IT IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES ON ITS PRINCIPAL OPERATIONS, THE FOUNDATION IS SUBJECT TO FEDERAL INCOME TAXES ON THE NET INCOME FROM ANY OPERATIONS IDENTIFIED BY THE INTERNAL REVENUE SERVICE TO GENERATE UNRELATED BUSINESS INCOME. NO SUCH UNRELATED BUSINESS INCOME TAX WAS INCURRED DURING 2018 OR 2017. THE FOUNDATION FOLLOWS THE STANDARDS FOR EVALUATING UNCERTAIN TAX POSITIONS AND HAS DETERMINED NO LIABILITY SHOULD BE RECORDED FOR UNCERTAIN TAX POSITIONS. PART XI, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD FOR MERCHANDISE SALES 6,633. RETURN OF PRIOR YEAR GRANT 24,588. PART XII, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD FOR MERCHANDISE SALES 6,633. RETURN OF PRIOR YEAR GRANT -9,275. 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION N/A 80000 EAST ASIA & THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION N/A 80000 0 0 0 0 0 0 160000 0 160000 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM INVESTIGATE ROLE OF MITOCHONDRIAL FITNESS IN PLYCYSTIC KIDNEY DISEASE PROGRESSION 80000 ACH TRANSFER BOOK EAST ASIA & THE PACIFIC UNDERSTANDING ROLE OF SOMANTIC VARIATION AND NOVEL MUTATIONAL MECHANISMS 40000 ACH TRANSFER BOOK 2 0 0 0 0 0 0 0 PART I, LINE 2: ALL GRANTEES ARE REQUIRED TO SUBMIT AN ANNUAL RESEARCH PROGRESS REPORT AND AN ANNUAL INSTITUTIONAL FINANCIAL STATUS REPORT. MOST GRANTEES ARE ALSO REQUIRED TO SUBMIT INTERIM QUARTERLY PROGRESS REPORTS. PART I, LINE 3: EXPENDITURES ARE REPORTED AT THE AMOUNT OF THE GRANT AWARDED AND ARE ACCOUNTED FOR USING THE SAME METHOD IN THE ORGANIZATION'S FINANCIAL STATEMENTS. X X X X X X 1 NEWPORT ONE 21 RAILROAD AVE DUXBURY MA 02332 MANAGED DIRECT MAIL EFFORTS 0 674547 452119 222428 GABRIEL GROUP 3190 RIDER TRAIL SOUTH EARTH CITY MO 63045 CREATE, PRINT AND SEND DIRECT MAIL CONTRIBUTION SOLICITATION 0 77895 51980 25915 752442 504099 248343 AK AL AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN MS NC ND NH NJ NM NV NY OH OK OR PA RI SC TN UT VA WA WI WV SCHEDULE G, PART I, LINE 2B, COLUMN (V) PAID PROFESSIONAL FUNDRAISER TO CREATE, PRINT AND SEND DIRECT MAIL CONTRIBUTION SOLICITATIONS. PAYMENTS WERE MADE BY CHECK. 1 UNIVERSITY OF COLORADO PO BOX 910439 DENVER CO 80921 846000555 501(C)(3) 80000 UNDERSTANDING THE ROLE OF CD8+ T-CELLS IN HALTING RENAL CYSTOGENESIS UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE MSN 1039 3901 RAINBOW BLVD KANSAS CITY KS 66103 481108830 501(C)(3) 80000 MECHANISM OF POLYCYSTIN-1-REGULATED G PROTEIN SIGNALING AND ITS ROLE IN THE PATHOGENESIS AND TREATMENT OF PKD YALE UNIVERSITY PO BOX 1872 NEW HAVEN CT 06508 060646973 501(C)(3) 80000 GENETIC APPROACH TO DEFINE MEDIATORS OF POLYCYSTIN-1 FUNCTION IN POLYCYSTIC KIDNEY DISEASE NORTHWESTERN UNIVERSITY-ASRSP CASH MANAGEMENT 633 CLARK STREET EVANSTON IL 602081112 362167817 501(C)(3) 80000 THE MOLECULAR AND MECHANISTIC IMPACTS OF FINGER 1 VARIANTS ON PKD2 ION CHANNEL FUNCTION IN THE PRIMARY CILIA. MEDICAL UNIVERSITY OF SOUTH CAROLINA 19 HAGOOD AVE MSC 808 CHARLESTON SC 294035120 576000722 GOV 80000 EFFECTS OF DIETARY SALT RESTRICTION ON CYSTOGENESIS IN ARPKD YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 065081873 060646973 501(C)(3) 80000 ROLE OF INTERSTITIAL CELLS IN RENAL CYSTOGENESIS REGENTS OF THE UNIVERSITY OF CALIFORNIA PO BOX 748872 LOS ANGELES CA 900744872 943067788 501(C)(3) 80000 UNDERSTANDING HOW THE CILIARY TRANSITION ZONE CONTROLS POLYCYSTIN-2 LOCALIZATION TO CILIA PRESIDENT AND FELLOWS OF HARVARD COLLEGE PO BOX 415649 BOSTON MA 022415649 042103580 501(C)(3) 80000 TAKING PKD OUT OF THE KIDNEY: DISSECTION OF POLYCYSTIN SIGNALING IN A NOVEL CELL-BASED SYSTEM CLEVELAND CLINIC FOUNDATION PO BOX 931531 CLEVELAND OH 441935012 912153073 501(C)(3) 80000 REGULATION OF CILIARY G-PROTEIN SIGNALING BY POLYCYSTIN-1 THE CHILDREN'S MERCY HOSPITAL PO BOX 803852 KANSAS CITY MO 641803852 440605373 501(C)(3) 80000 MOLECULAR CHARACTERIZATION OF CYST FORMATION IN A PORCINE MODEL OF EARLY ADPKD UNIVERSITY OF MARYLAND BALTIMORE PO BOX 41428 BALTIMORE MD 212036428 526002033 GOV 80000 DISRUPTION OF THE APICAL JUNCTIONAL COMPLEX IN CYSTOGENESIS AND ADPKD ST JOHN'S UNIVERSITY 8000 UTOPIA PARK QUEENS NY 11438 111630830 501(C)(3) 80000 THE ROLE OF POLYCYSTIN-1 IN THE POLYCYSTIN-1/POLYCYSTIN-2 ION CHANNEL COMPLEX MAYO CLINIC PO BOX 860334 MINNEAPOLIS MN 55486 416011702 501(C)(3) 80000 THE ROLES OF DNA METHYLATION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 065081873 060646973 501(C)(3) 60000 TARGETING THE CELL CYCLE AS A POTENTIAL TREATMENT FOR ADPKD: THE ROLE OF CYCLIN-DEPENDENT KINASE 1 MAYO CLINIC PO BOX 860334 MINNEAPOLIS MN 55486 416011702 501(C)(3) 60000 RESTORING CILIARY LEVEL OF FUNCTIONAL POLYCYSTINS AS A NOVEL THERAPEUTIC APPROACH FOR ADPKD TREATMENT MAYO CLINIC PO BOX 860334 MINNEAPOLIS MN 55486 416011702 501(C)(3) 40000 RESOURCING PKD IMAGING BIOMARKERS PILOT: AUTOMATED TKV UNIVERSITY OF IOWAIUPUI 420 UNIVERSITY BLDV INDIANAPOLIS IN 46202 426004813 GOV 52624 PIOGLITAZONE STUDY MAYO CLINIC PO BOX 860334 MINNEAPOLIS MN 55486 416011702 501(C)(3) 40000 ADPKD MUTATION DATABASE 12 0 PART I, LINE 2: ALL GRANTEES ARE REQUIRED TO SUBMIT AN ANNUAL RESEARCH PROGRESS REPORT AND AN ANNUAL INSTITUTIONAL FINANCIAL STATUS REPORT. MOST GRANTEES ARE ALSO REQUIRED TO SUBMIT INTERIM QUARTERLY PROGRESS REPORTS. X X X X 0 0 0 0 0 0 0 0 0 BETTS ANDREW CEO 220000 0 0 0 0 0 17325 0 4272 0 241597 0 0 0 BARON DAVID CHIEF SCIENTIFIC OFFICER 187200 0 18720 0 0 0 24000 0 15444 0 245364 0 0 0 X 17 1142528 FAIR VALUE X EVENT ITEMS 220 144313 FAIR VALUE 0 1 1 PART I, LINE 32B: ORGANIZATION UTILIZES ONGOING BANKING RELATIONSHIPS TO MARKET DONATED SECURITIES. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. PRIOR TO FILING THE FORM 990 FOR PKD FOUNDATION, A DRAFT COPY WILL BE PROVIDED TO THE BOARD OF TRUSTEES FOR REVIEW AND COMMENT. ANY COMMENTS WILL BE ACCUMULATED BY MANAGEMENT AND ADDRESSED ACCORDINGLY PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C MEMBERS OF THE BOARD OF TRUSTEES OF PKD FOUNDATION ARE REQUIRED TO SIGN AN ANNUAL STATEMENT DISCLOSING ANY CONFLICTS OF INTEREST. THE GOVERNANCE COMMITTEE REVIEWS THE STATEMENTS AND ENSURES THAT BOARD MEMBERS ARE PROHIBITED FROM PARTICIPATING IN DISCUSSIONS OR DECISIONS RELATED TO TRANSACTIONS THAT INVOLVE ACTUAL CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 ANNUALLY, THE CHAIRMAN OF THE BOARD OF TRUSTEES WORKS WITH THE CEO TO DEVELOP THE CEO'S GOALS FOR THE NEW FISCAL YEAR. AT THE END OF EACH FISCAL YEAR, THE EXECUTIVE COMMITTEE EVALUATES THE CEO AGAINST THESE GOALS AND RECOMMENDS TO THE BOARD THE CEO'S COMPENSATION PACKAGE FOR APPROVAL, BASED ON THIS EVALUATION. ANNUALLY, THE EXECUTIVE COMMITTEE REVIEWS A NATIONAL SALARY SURVEY CONDUCTED BY AN INDEPENDENT CONSULTANT. UPON THAT REVIEW, SALARIES ARE COMPARED TO THE RANGES RECOMMENDED FOR EACH POSITION. FOUNDATION MANAGEMENT THEN ACTS TO ENSURE THAT SALARIES ARE WITHIN APPROPRIATE RANGES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON THEIR OWN WEBSITE AND UPON REQUEST. FORM 990, PART VII, SECTION A, LINE 1: PKD FOUNDATION CONTRACTS WITH ADP TOTALSOURCE TO PROVIDE CERTAIN EMPLOYEE BENEFITS AND PAYROLL SERVICES. EMPLOYEES ARE CONSIDERED TO BE JOINTLY EMPLOYED BY BOTH PKD FOUNDATION AND ADP TOTALSOURCE. IN ORDER TO COMPLY WITH TRANSPARENCY DIRECTIVES AS A PART OF THE FORM 990, THE FOUNDATION HAS DECIDED TO REPORT COMPENSATION IN PART VII TO INCLUDE AMOUNTS PAID AND REPORTED ON W-2'S BY ADP TOTALSOURCE. FORM 990, PART IX, LINE 11G PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 965,644. MANAGEMENT AND GENERAL EXPENSES 37,546. FUNDRAISING EXPENSES 49,865. TOTAL EXPENSES 1,053,055. FORM 990, PART XI, LINE 9: RETURN OF PRIOR YEAR GRANT 33,863. FORM 990, PART XII, LINE 2C: NO CHANGE FROM THE PRIOR YEAR.